# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-049317
Filing Date
2024-12-09
Accepted
2024-12-09 17:25:54
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefa14a.htm | DEFA14A | 24889
2 |  | ex1_001.jpg | GRAPHIC | 450472
3 |  | ex1_002.jpg | GRAPHIC | 522621
4 |  | ex2_001.jpg | GRAPHIC | 360617
5 |  | ex2_002.jpg | GRAPHIC | 91171
| Complete submission text file | 0001493152-24-049317.txt |  | 1988836

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-27072 | Film No.: 241536376
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)